Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-24 @ 7:19 PM
NCT ID:
NCT00260403
Eligibility Criteria:
Inclusion Criteria: Informed consent. Occult or minimally classic choroidal neovascularization. Lesion size \< 5 mm. VA 0.1-0.5. Recent disease progress.
\< 25% subretinal fibrosis. No contraindications to fluoresceinangiography and ICG.
\-
Exclusion Criteria: Earlier treatment with argonlaser or PDT, or otherwise treated in the eye with radiation or PPV. Submacular hemorrhage \> 50%. Serous PED \> 25%. Geographic atrophy \> 1 disc and \< 500 um from fovea. Chorioretinal anastomosis. Glaucoma. Diabetes retinopathy with \> 5 microaneurysm. Contraindications to fluoresceinangiography or ICG. Enrollment in other studies. Drugaddiction.
\-
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
85 Years
Study:
NCT00260403
Study Brief:
Protocol Section:
NCT00260403